|

177Lu-RAD204 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Radiopharm Theranostics, Ltd1

Indications

  • PDL1 Gene Mutation1
  • MSI-High1
  • Mmr Deficiency1
  • TNBC - Triple-Negative Breast Cancer1
  • Small Cell Lung Cancer (SCLC)1

Other1 trial

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.